{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T17:17:19Z","timestamp":1786123039825,"version":"build-2736575974"},"reference-count":82,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"am","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Fixed drug eruption (FDE) is a common cutaneous adverse reaction characterized by recurrent, well-demarcated lesions appearing at the same site upon re-exposure to a causative drug. Genital involvement represents one of the most frequent mucosal localizations in men but remains poorly described in the literature, often leading to diagnostic confusion with sexually transmitted infections.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To systematically review the epidemiological, clinical and aetiological characteristics of male genital FDE.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A systematic review was conducted according to the PRISMA 2020 guidelines. MEDLINE, Google Scholar, Embase and the Cochrane Library were searched for articles published between 1970 and 2024, using predefined keywords relating to FDE and male genital involvement. Eligible publications included case reports and case series describing genital FDE in adult male patients. Data on demographics, clinical presentation, drug triggers, diagnostic methods and extragenital involvement were extracted. Weighted medians and means were calculated when applicable.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Seventy studies were included, encompassing 262 male patients. The weighted median age was 35.5\u2005years. Genital lesions were most commonly located on the glans penis (72.9%), followed by the shaft (17.6%), foreskin (12.2%) and scrotum (4.2%). Erythema (85.9%) was the predominant clinical presentation, while erosions (36.3%), bullae (26.7%) and postinflammatory pigmentation (24.4%) were variably reported. In 79.0% of cases, genital involvement was isolated. Among extragenital sites, the oral mucosa was most frequently affected (54.5%). A causative agent was identified in 93.1% of patients. The most commonly implicated drugs were trimethoprim\u2013sulfamethoxazole (27.9%), cyclines (20.9%) and nonsteroidal anti-\u00adinflammatory drugs (NSAIDs; 12.3%). The weighted median time to onset was 48\u2005h. Diagnosis relied solely on clinical history in 56.1% of patients, with oral provocation tests most frequently used when further allergy investigations were performed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This review represents the largest synthesis of male genital FDE to date. The condition predominantly affects the glans and is most commonly induced by antibiotics and NSAIDs. Recognizing its characteristic presentation and drug associations is essential to differentiate it from sexually transmitted infections and avoid recurrent episodes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ced\/llag275","type":"journal-article","created":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T11:48:44Z","timestamp":1782388124000},"source":"Crossref","is-referenced-by-count":0,"title":["Male genital fixed drug eruption: a systematic review"],"prefix":"10.1093","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4411-7289","authenticated-orcid":false,"given":"Romain","family":"Salle","sequence":"first","affiliation":[{"name":"Department of General and Oncologic Dermatology, Ambroise-Par\u00e9 Hospital , AP-HP, Boulogne-Billancourt ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Marcellier","sequence":"additional","affiliation":[{"name":"Endoscopy Unit, Beaujon Hospital , AP-HP, Clichy ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tu-Anh","family":"Duong","sequence":"additional","affiliation":[{"name":"Department of General and Oncologic Dermatology, Ambroise-Par\u00e9 Hospital , AP-HP, Boulogne-Billancourt ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-No\u00ebl","family":"Dauendorffer","sequence":"additional","affiliation":[{"name":"Centre for Genital and Sexually Transmitted Diseases \u2013 Dermatology Department, Saint-Louis Hospital , AP-HP, Paris ,","place":["France"]},{"name":"Universit\u00e9 Paris-Saclay, UVSQ , Montigny-Le-Bretonneux ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,6,26]]},"reference":[{"key":"2026080709364482400_llag275-B1","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s40257-020-00505-3","article-title":"Fixed drug eruptions: an update, emphasizing the potentially lethal generalized bullous fixed drug eruption","volume":"21","author":"Patel","year":"2020","journal-title":"Am J Clin Dermatol"},{"key":"2026080709364482400_llag275-B2","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1684\/ejd.2010.0980","article-title":"A three-year-analysis of fixed drug eruptions in hospital settings in France","volume":"20","author":"Brahimi","year":"2010","journal-title":"Eur J Dermatol"},{"key":"2026080709364482400_llag275-B3","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/S0190-9622(03)01588-3","article-title":"Specific site involvement in fixed drug eruption","volume":"49","author":"Ozkaya-Bayazit","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"2026080709364482400_llag275-B4","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"2026080709364482400_llag275-B5","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/cod.14500","article-title":"Triggers, clinical manifestations and assessment of paediatric fixed drug eruptions: a systematic review of the literature","volume":"90","author":"Mathieu","year":"2024","journal-title":"Contact Dermatitis"},{"key":"2026080709364482400_llag275-B6","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1111\/ijd.17989","article-title":"Clinical characteristics of adult localized and generalized fixed drug eruptions: a systematic review","volume":"65","author":"Choi","year":"2026","journal-title":"Int J Dermatol"},{"key":"2026080709364482400_llag275-B7","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.jaip.2023.10.021","article-title":"In situ patch test and repeated open application test for fixed drug eruption: a multicentre study","volume":"12","author":"Traineau","year":"2024","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2026080709364482400_llag275-B8","doi-asserted-by":"crossref","first-page":"e303","DOI":"10.1111\/jdv.20280","article-title":"Doxycycline-induced fixed drug eruption: the new epidemic?","volume":"39","author":"Brehon","year":"2025","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2026080709364482400_llag275-B9","first-page":"242","article-title":"Fixed drug eruptions occurring on the male genitals","volume":"45","author":"Gaffoor","year":"1990","journal-title":"Cutis"},{"key":"2026080709364482400_llag275-B10","first-page":"56","article-title":"Genital fixed drug eruptions","volume":"62","author":"Sehgal","year":"1986","journal-title":"Genitourin Med"},{"key":"2026080709364482400_llag275-B11","doi-asserted-by":"crossref","first-page":"89","DOI":"10.22159\/ajpcr.2023.v16i6.47431","article-title":"A cross-sectional study of fixed drug eruption of male and female genitalia at a tertiary hospital of middle Gujarat, India","volume":"16","author":"Tralsawala","year":"2023","journal-title":"Asian J Pharm Clin Res"},{"key":"2026080709364482400_llag275-B12","doi-asserted-by":"crossref","first-page":"108335","DOI":"10.1016\/j.ijid.2025.108335","article-title":"Doxycycline-induced fixed drug eruption: a case series highlighting a dermatological concern in antimicrobial stewardship","volume":"164","author":"Brun","year":"2026","journal-title":"Int J Infect Dis"},{"key":"2026080709364482400_llag275-B13","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1258\/0956462041558285","article-title":"Fixed drug eruption \u2013 a sexually inducible reaction?","volume":"15","author":"Zawar","year":"2004","journal-title":"Int J STD AIDS"},{"key":"2026080709364482400_llag275-B14","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1016\/S0140-6736(16)30378-6","article-title":"Severe cutaneous adverse reactions to drugs","volume":"390","author":"Duong","year":"2017","journal-title":"Lancet"},{"key":"2026080709364482400_llag275-B15","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1097\/00007435-198407000-00009","article-title":"Fixed drug eruptions on male genitalia: clinical and etiologic study","volume":"11","author":"Pandhi","year":"1984","journal-title":"Sex Transm Dis"},{"key":"2026080709364482400_llag275-B16","first-page":"116","article-title":"Fixed drug eruption in male genitalia: a cross-sectional study from Iran","volume":"18","author":"Yazdanpanah","year":"2015","journal-title":"Iran J Dermatol"},{"key":"2026080709364482400_llag275-B17","first-page":"91","article-title":"Genital fixed drug eruption. A study of 69 cases","volume":"20","author":"Mu\u00f1oz Estrada","year":"2011","journal-title":"Revista Centro Dermatol Pascua"},{"key":"2026080709364482400_llag275-B18","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1111\/j.1365-2133.1970.tb06104.x","article-title":"Fixed drug eruption due to cyclizine","volume":"82","author":"Griffiths","year":"1970","journal-title":"Br J Dermatol"},{"key":"2026080709364482400_llag275-B19","first-page":"42","article-title":"Balanitis due to fixed drug eruption associated with tetracycline therapy","volume":"47","author":"Csonka","year":"1971","journal-title":"Br J Vener Dis"},{"key":"2026080709364482400_llag275-B20","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1440-0960.1973.tb00704.x","article-title":"Fixed drug eruption due to tetracycline \u2013 a report of a case","volume":"14","author":"Armati","year":"1973","journal-title":"Australas J Dermatol"},{"key":"2026080709364482400_llag275-B21","first-page":"316","article-title":"Balanitis due to fixed eruption after Mandrax","volume":"49","author":"Csonka","year":"1973","journal-title":"Br J Vener Dis"},{"key":"2026080709364482400_llag275-B22","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.1974.03230200059020","article-title":"Letter: tetracycline balanitis: fixed drug reaction","volume":"227","author":"Brown","year":"1974","journal-title":"JAMA"},{"key":"2026080709364482400_llag275-B23","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1365-4362.1974.tb01758.x","article-title":"Erythema fixum of the genitals and the mucous membranes","volume":"13","author":"Kuokkanen","year":"1974","journal-title":"Int J Dermatol"},{"key":"2026080709364482400_llag275-B24","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1346-8138.1977.tb01015.x","article-title":"A case of minocycline-induced fixed drug eruption","volume":"4","author":"Shimizu","year":"1977","journal-title":"J Dermatol"},{"key":"2026080709364482400_llag275-B25","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/00007435-198101000-00009","article-title":"Pigmented penile lesions (fixed drug eruptions) associated with tetracycline therapy for sexually transmitted diseases","volume":"8","author":"Fiumara","year":"1981","journal-title":"Sex Transm Dis"},{"key":"2026080709364482400_llag275-B26","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0190-9622(83)80199-6","article-title":"Fixed drug eruption due to minocycline \u2013 report of one case","volume":"8","author":"LePaw","year":"1983","journal-title":"J Am Acad Dermatol"},{"key":"2026080709364482400_llag275-B27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0090-4295(84)90165-1","article-title":"Papulosquamous lesions of glans penis","volume":"23","author":"Horan","year":"1984","journal-title":"Urology"},{"key":"2026080709364482400_llag275-B28","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/S0190-9622(84)80480-6","article-title":"Lack of cross-sensitivity between tetracycline, doxycycline, and minocycline with regard to fixed drug sensitivity to tetracycline","volume":"11","author":"Bargman","year":"1984","journal-title":"J Am Acad Dermatol"},{"key":"2026080709364482400_llag275-B29","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/S0022-5347(17)49372-4","article-title":"Balanitis as a fixed drug eruption to tetracycline","volume":"133","author":"Dodds","year":"1985","journal-title":"J Urol"},{"key":"2026080709364482400_llag275-B30","first-page":"51","article-title":"Fixed drug eruption to paracetamol","volume":"179","author":"Valsecchi","year":"1989","journal-title":"Dermatologica"},{"key":"2026080709364482400_llag275-B31","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S0190-9622(89)80089-1","article-title":"Fixed drug eruption due to dimenhydrinate","volume":"20","author":"Hogan","year":"1989","journal-title":"J Am Acad Dermatol"},{"key":"2026080709364482400_llag275-B32","first-page":"97","article-title":"Fixed drug eruption due to foscarnet","volume":"66","author":"Connolly","year":"1990","journal-title":"Genitourin Med"},{"key":"2026080709364482400_llag275-B33","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1111\/j.1365-4362.1990.tb03788.x","article-title":"Fixed drug eruption and cross-reactivity between tinidazole and metronidazole","volume":"29","author":"Mishra","year":"1990","journal-title":"Int J Dermatol"},{"key":"2026080709364482400_llag275-B34","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1111\/j.1365-4362.1991.tb02633.x","article-title":"Fixed drug eruption caused by erythromycin","volume":"30","author":"Mutalik","year":"1991","journal-title":"Int J Dermatol"},{"key":"2026080709364482400_llag275-B35","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/0090-4295(94)90161-9","article-title":"Fixed drug eruption to papaverine","volume":"43","author":"Kirby","year":"1994","journal-title":"Urology"},{"key":"2026080709364482400_llag275-B36","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/S0091-6749(96)70275-0","article-title":"Successful desensitization for treatment of a fixed drug eruption to allopurinol","volume":"97","author":"Kelso","year":"1996","journal-title":"J Allergy Clin Immunol"},{"key":"2026080709364482400_llag275-B37","first-page":"61","article-title":"Fixed drug eruption due to colchicine","volume":"192","author":"Mochida","year":"1996","journal-title":"Dermatology"},{"key":"2026080709364482400_llag275-B38","first-page":"127","article-title":"Fixed drug eruption induced by lidocaine and patch testing","volume":"7","author":"Garc\u00eda","year":"1997","journal-title":"J Investig Allergol Clin Immunol"},{"key":"2026080709364482400_llag275-B39","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1080\/00015559850135913","article-title":"Fixed drug eruption due to melatonin","volume":"78","author":"Bardazzi","year":"1998","journal-title":"Acta Derm Venereol"},{"key":"2026080709364482400_llag275-B40","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/S0091-6749(98)70396-3","article-title":"Successful desensitization of a fixed drug eruption caused by allopurinol","volume":"101","author":"Umpi\u00e9rrez","year":"1998","journal-title":"J Allergy Clin Immunol"},{"key":"2026080709364482400_llag275-B41","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/j.1600-0536.1999.tb06045.x","article-title":"Fixed drug eruptions due to betalactams and other chemically unrelated antibiotics","volume":"40","author":"Saenz de San Pedro Morera","year":"1999","journal-title":"Contact Dermatitis"},{"key":"2026080709364482400_llag275-B42","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1046\/j.1365-2230.1999.00436.x","article-title":"Genital fixed drug eruption: cross-reactivity between doxycycline and minocycline","volume":"24","author":"Correia","year":"1999","journal-title":"Clin Exp Dermatol"},{"key":"2026080709364482400_llag275-B43","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1600-0536.1999.tb06127.x","article-title":"Topical provocation in 27 cases of cotrimoxazole-induced fixed drug eruption","volume":"41","author":"Ozkaya-Bayazit","year":"1999","journal-title":"Contact Dermatitis"},{"key":"2026080709364482400_llag275-B44","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0301-0546(03)79165-4","article-title":"Non-pigmenting cutaneous\u2013mucosal fixed drug eruption due to piroxicam","volume":"31","author":"Montoro","year":"2003","journal-title":"Allergol Immunopathol (Madr)"},{"key":"2026080709364482400_llag275-B45","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1159\/000077308","article-title":"Fixed drug eruption of the penis due to zolmitriptan","volume":"208","author":"Baykal","year":"2004","journal-title":"Dermatology"},{"key":"2026080709364482400_llag275-B46","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1111\/j.1365-4632.2004.02454.x","article-title":"Fixed drug eruption: a novel side-effect of levocetirizine","volume":"44","author":"Mahajan","year":"2005","journal-title":"Int J Dermatol"},{"key":"2026080709364482400_llag275-B47","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1100\/tsw.2006.361","article-title":"Fixed drug eruption of the penis secondary to sulfamethoxazole\u2013trimethoprim","volume":"6","author":"Lawrentschuk","year":"2006","journal-title":"Sci World J"},{"key":"2026080709364482400_llag275-B48","doi-asserted-by":"crossref","first-page":"128","DOI":"10.2310\/7750.2006.00035","article-title":"Cutaneous reaction to drugs used for erectile dysfunction: case report and review of the literature","volume":"10","author":"Beach","year":"2006","journal-title":"J Cutan Med Surg"},{"key":"2026080709364482400_llag275-B49","doi-asserted-by":"crossref","first-page":"12","DOI":"10.5070\/D30QK2338P","article-title":"Unilateral non-pigmenting fixed drug eruption associated with cotrimoxazole","volume":"12","author":"Rasi","year":"2006","journal-title":"Dermatol Online J"},{"key":"2026080709364482400_llag275-B50","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1080\/09546630701759561","article-title":"Doxycycline-induced fixed drug eruption","volume":"19","author":"Gul","year":"2008","journal-title":"J Dermatolog Treat"},{"key":"2026080709364482400_llag275-B51","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jaad.2008.07.037","article-title":"Solitary fixed drug eruption caused by finasteride","volume":"60","author":"Oyama","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"2026080709364482400_llag275-B52","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.semerg.2010.08.006","article-title":"Fixed drug eruption: diagnostic keys","volume":"37","author":"Agusti-Mejias","year":"2011","journal-title":"Semergen"},{"key":"2026080709364482400_llag275-B53","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1001\/archdermatol.2011.32","article-title":"Fixed drug eruption on the penis due to oxcarbazepine","volume":"147","author":"Schuster","year":"2011","journal-title":"Arch Dermatol"},{"key":"2026080709364482400_llag275-B54","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1111\/j.1743-6109.2011.02578.x","article-title":"Postcoital penile drug eruption in a co-trimoxazole-sensitive patient following vaginal use of triple sulfa vaginal cream by his partner","volume":"9","author":"Zargooshi","year":"2012","journal-title":"J Sex Med"},{"key":"2026080709364482400_llag275-B55","first-page":"48","article-title":"Fixed-drug eruption caused by ashwagandha (Withania somnifera): a widely used Ayurvedic drug","volume":"10","author":"Sehgal","year":"2012","journal-title":"Skinmed"},{"key":"2026080709364482400_llag275-B56","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.anai.2012.01.002","article-title":"In vitro cytokine production after in vivo desensitization in an allopurinol-induced delayed allergic reaction","volume":"108","author":"Mart\u00ednez-Aranguren","year":"2012","journal-title":"Ann Allergy Asthma Immunol"},{"key":"2026080709364482400_llag275-B57","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/DER.0b013e318262cac2","article-title":"Fixed drug eruption to ingested propolis","volume":"23","author":"Ramien","year":"2012","journal-title":"Dermatitis"},{"key":"2026080709364482400_llag275-B58","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1590\/abd1806-4841.20131994","article-title":"Fixed drug eruption caused by tadalafil \u2013 case report","volume":"88","author":"Bjekic","year":"2013","journal-title":"An Bras Dermatol"},{"key":"2026080709364482400_llag275-B59","first-page":"703","article-title":"Genital fixed drug eruption induced by miconazole with positive provocation test","volume":"92","author":"Kastalli","year":"2014","journal-title":"Tunis Med"},{"key":"2026080709364482400_llag275-B60","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.aller.2012.11.003","article-title":"First multifocal bullous fixed drug eruption due to etodolac","volume":"42","author":"Koca Kalkan","year":"2014","journal-title":"Allergol Immunopathol (Madr)"},{"key":"2026080709364482400_llag275-B61","first-page":"62","article-title":"Penile ulceration due to doxicycline: a case report about fixed drug eruption","volume":"2014","author":"Kati","year":"2014","journal-title":"N J Urol"},{"key":"2026080709364482400_llag275-B62","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1136\/sextrans-2013-051458","article-title":"A case of fixed drug eruption secondary to quinine in tonic water presenting to a sexual health clinic","volume":"90","author":"Lonsdale-Eccles","year":"2014","journal-title":"Sex Transm Infect"},{"key":"2026080709364482400_llag275-B63","doi-asserted-by":"crossref","first-page":"167","DOI":"10.4103\/2229-5178.131091","article-title":"Non pigmenting mucosal fixed drug eruption due to tadalafil: a report of two cases","volume":"5","author":"Das","year":"2014","journal-title":"Indian Dermatol Online J"},{"key":"2026080709364482400_llag275-B64","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1177\/0310057X1404200614","article-title":"Fixed drug eruption to propofol","volume":"42","author":"Allchurch","year":"2014","journal-title":"Anaesth Intensive Care"},{"key":"2026080709364482400_llag275-B65","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/j.0105-1873.2005.0654b.x","article-title":"Fixed drug eruption caused by ornidazole","volume":"53","author":"Gupta","year":"2005","journal-title":"Contact Dermatitis"},{"key":"2026080709364482400_llag275-B66","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1097\/OLQ.0000000000000173","article-title":"A \u2018sexually transmitted\u2019 fixed drug reaction","volume":"41","author":"Maatouk","year":"2014","journal-title":"Sex Transm Dis"},{"key":"2026080709364482400_llag275-B67","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.jemermed.2014.09.049","article-title":"Bullous fixed drug eruption masquerading as recurrent Stevens Johnson syndrome","volume":"48","author":"Dharamsi","year":"2015","journal-title":"J Emerg Med"},{"key":"2026080709364482400_llag275-B68","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.alit.2015.04.007","article-title":"A case of fixed drug eruption caused by loxoprofen sodium hydrate","volume":"64","author":"Nakai","year":"2015","journal-title":"Allergol Int"},{"key":"2026080709364482400_llag275-B69","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1016\/j.jdiacomp.2016.08.002","article-title":"Possible new inflammatory side-effect of SGLT2-inhibitors: fixed drug eruption","volume":"30","author":"Damiani","year":"2016","journal-title":"J Diabetes Complications"},{"key":"2026080709364482400_llag275-B70","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.purol.2016.05.001","article-title":"Bullous fixed drug eruption of the glands due to tadalafil: a case report","volume":"26","author":"Grimaux","year":"2016","journal-title":"Prog Urol"},{"key":"2026080709364482400_llag275-B71","first-page":"44","article-title":"Fixed drug eruption to supplement containing ginkgo biloba and vinpocetine: a case report and review of related cutaneous side effects","volume":"10","author":"Cohen","year":"2017","journal-title":"J Clin Aesthet Dermatol"},{"key":"2026080709364482400_llag275-B72","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1080\/17843286.2018.1484983","article-title":"Fixed drug eruption due to 2,3-dimercapto-1-propanesulfonic acid (DMPS) treatment for mercury poisoning: a rare adverse effect","volume":"74","author":"Erden","year":"2019","journal-title":"Acta Clin Belg"},{"key":"2026080709364482400_llag275-B73","first-page":"51","article-title":"Bullous fixed drug eruption following ibuprofen ingestion","volume":"7","author":"Fazeli","year":"2018","journal-title":"J Res Pharm Pract"},{"key":"2026080709364482400_llag275-B74","doi-asserted-by":"crossref","first-page":"42","DOI":"10.4103\/CDR.CDR_24_17","article-title":"Doxofylline: another drug causing fixed drug eruption","volume":"2","author":"Kumudhini","year":"2018","journal-title":"Clin Dermatol Rev"},{"key":"2026080709364482400_llag275-B75","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.therap.2018.01.005","article-title":"Mucosal fixed drug eruption due to mefenamic acid: report of a case and a review","volume":"73","author":"Zaouak","year":"2018","journal-title":"Therapie"},{"key":"2026080709364482400_llag275-B76","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/ced.13740","article-title":"Neutrophilic fixed drug eruption: a mimic of neutrophilic dermatoses","volume":"44","author":"Suzuki","year":"2019","journal-title":"Clin Exp Dermatol"},{"key":"2026080709364482400_llag275-B77","doi-asserted-by":"crossref","first-page":"1000142","DOI":"10.35248\/2684-124X.18.3.142","article-title":"Multiple fixed drug eruption due to piroxicam: a brief case report","volume":"3","author":"Imtihani","year":"2018","journal-title":"Dermatol Case Rep"},{"key":"2026080709364482400_llag275-B78","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/ced.13701","article-title":"Fixed drug eruption caused by drinking alcohol","volume":"44","author":"Zhang","year":"2019","journal-title":"Clin Exp Dermatol"},{"key":"2026080709364482400_llag275-B79","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jdcr.2022.08.041","article-title":"Nicotine-induced bullous fixed drug eruption","volume":"29","author":"Sargent","year":"2022","journal-title":"JAAD Case Rep"},{"key":"2026080709364482400_llag275-B80","doi-asserted-by":"crossref","first-page":"627","DOI":"10.4103\/ijd.ijd_18_22","article-title":"Nicorandil-induced bullous fixed drug eruption on the glans penis","volume":"67","author":"Ghosh","year":"2022","journal-title":"Indian J Dermatol"},{"key":"2026080709364482400_llag275-B81","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jdcr.2023.10.024","article-title":"A case of bullous fixed drug eruption caused by tadalafil","volume":"45","author":"Zhang","year":"2024","journal-title":"JAAD Case Rep"},{"key":"2026080709364482400_llag275-B82","first-page":"e65422","article-title":"Fixed drug eruption on the penis due to trimethoprim-sulfamethoxazole: a case report","volume":"16","author":"Shapiro","year":"2024","journal-title":"Cureus"}],"container-title":["Clinical and Experimental Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ced\/advance-article-pdf\/doi\/10.1093\/ced\/llag275\/68625372\/llag275.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ced\/advance-article-pdf\/doi\/10.1093\/ced\/llag275\/68625372\/llag275.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T13:37:02Z","timestamp":1786109822000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ced\/advance-article\/doi\/10.1093\/ced\/llag275\/8718752"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,26]]},"references-count":82,"URL":"https:\/\/doi.org\/10.1093\/ced\/llag275","relation":{},"ISSN":["0307-6938","1365-2230"],"issn-type":[{"value":"0307-6938","type":"print"},{"value":"1365-2230","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,26]]},"article-number":"llag275"}}